ITMCTR2022000106尚未招募1 期
Efficacy evaluation and mechanism study of Yiqi Huashi and Jiedu Tongluo methods in chronic liver disease
试验速览
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 年龄范围
- 18 至 65（—）
- 性别
- All
入选标准
- •1. Meet the diagnostic criteria for alcoholic liver disease and have liver function ALT, AST or ?-GT greater than 1.5 times the normal value at the time of enrollment;
- •2. Meet the the syndrome differentiation criteria of Ganyu Pixu and Shire Neijie;
- •3. The age is between 18-65 years old, and the gender is not limited;
- •4. Willing to participate in this research and sign the informed consent.
排除标准
- •1. Patients with other liver diseases such as hepatitis B and C;
- •2. Patients with autoimmune liver disease, drug-induced liver disease, toxic hepatitis, liver cancer, non-alcoholic fatty liver disease, occult hepatitis, and unexplained liver disease;
- •3. Pregnant or lactating women, those with allergic constitution;
- •4. Patients with mental disorders who cannot cooperate with this study;
- •5. Patients with severe heart, brain, lung, kidney, hematopoietic, immune and other system diseases;
- •6. Other conditions deemed inappropriate by the researcher.(including people with alcohol dependence)
研究者
相似试验
招募中
1 期
Clinical study of Shugan Jianpi Huazhi Decoction combined with Tongluo Yanggan application in the treatment of non-alcoholic fatty liver diseaseITMCTR2022000098Guang'anmen Hospital, China Academy of Chinese Medical Sciences
招募中
1 期
Clinical study of Jianpi Yanggan Decoction combined with Tongluo Yanggan application in the treatment of autoimmune hepatitisAutoimmune HepatitisITMCTR2022000094Guang'anmen Hospital, China Academy of Chinese Medical Sciences
尚未招募
早期 1 期
A randomized, double-blind, placebo-controlled clinical study on Yinqi Sanhuang Jiedu Decoction combined with Tongluo Yanggan application in the treatment of hepatitis B-related liver fibrosisITMCTR2022000019Guang'anmen Hospital, China Academy of Chinese Medical Sciences
尚未招募
1 期
Study for the Effectiveness and Safety of Yi-Qi Hua-shi Jie-Du-Fang in the Treatment of the Novel Coronavirus Pneumonia (COVID-19)ovel Coronavirus Pneumonia (COVID-19)ITMCTR2000003080Affiliated Hospital of traditional Chinese and Western Medicine Nanjing University of Chinese Medicine
招募中
1 期
Study on the clinical efficacy of Yiqi Huoxue Jiedu formula in the treatment of platinum resistant ovarian cancer based on the phenotypic changes of macrophagesovarian cancerITMCTR2100005211Guang'anmen Hospital, Chinese Academy of traditional Chinese Medicine